|
Nov. 25th, 2021|01:30 pm |
https://youtu.be/2u3AYK808pw IVM tika laiciigi aizliegts... sk. komentus
"..the vaccines containing the full-length SARS-CoV-2 S protein could potentially trigger the complement pathway leading to thrombosis events." https://www.mdpi.com/2218-273X/11/7/1020/htm
https://pubmed.ncbi.nlm.nih.gov/34696485/
* Oxford/Astra-Zeneca adenovirus vector vaccine (ChAdOx1 nCoV‐19), Ad5 vector, the LNP- encapsulated mRNA vaccines from Pfizer/BioNTech (BNT162b2) and Moderna (mRNA‐1273), and the Novavax vaccine that uses the recombinant spike protein (NVX‐CoV2373). |
|